ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
Clinical trial NCT03689712 · COMPLETED
Trial details
- NCT number
- NCT03689712
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2021-08-13
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.